Migraine and Telehealth: How to Get Effective Care Remotely

Telehealth has transformed access to migraine care for many people who previously faced significant barriers to seeing a headache specialist. Geographic distance from academic medical centers, limited availability of neurologists in rural and underserved areas, mobility limitations during severe attack periods, and the time cost of in-person appointments have historically prevented many people with migraine from accessing specialist-level care. Telehealth eliminates or reduces each of these barriers, and the evidence from clinical studies suggests that telehealth delivery of migraine care produces outcomes comparable to in-person care for appropriately selected patients.

What Telehealth Can and Cannot Do for Migraine

Migraine is one of the conditions most amenable to telehealth delivery because its diagnosis and management are predominantly based on history rather than physical examination. The diagnostic criteria for migraine require a detailed account of attack characteristics, frequency, duration, and associated symptoms — all of which can be obtained via video or phone consultation.

Telehealth is particularly well suited to follow-up appointments for established migraine patients who have a known diagnosis and are being monitored for treatment response. Initiating a new preventive medication, adjusting doses, reviewing headache diary data, addressing medication overuse, and coordinating referrals can all be accomplished effectively through telehealth.

Telehealth has limitations. New patients with atypical presentations, significant neurological symptoms, or clinical uncertainty warrant in-person evaluation. Patients who need physical examination findings to guide diagnosis or who are being evaluated for procedures including Botox injections or nerve blocks need in-person contact for the procedural component of care.

Finding Telehealth Migraine Care

Several resources help people with migraine access telehealth care. The American Migraine Foundation's provider directory includes telehealth-capable providers. Dedicated headache-focused telehealth services have emerged that connect patients with headache specialists for both initial evaluation and ongoing management.

Many neurologists and headache specialists who previously offered only in-person care now offer hybrid models in which initial evaluation is in-person and follow-up care is through telehealth. This approach captures the benefits of physical examination at the outset while reducing the time burden of ongoing management.

Preparing for a Telehealth Migraine Appointment

Preparation for a telehealth appointment requires the same elements as preparation for an in-person visit but with additional attention to the technical environment. Ensuring a stable internet connection, a device with a working camera and microphone, adequate lighting, and a quiet private space allows the clinical encounter to proceed without avoidable interruptions.

The clinical preparation — headache diary data, prior treatment history, current medication list, and prepared questions — is identical to what would be brought to an in-person appointment. Sharing these documents with the provider before the appointment through the patient portal allows the clinician to review them in advance and use the appointment time more efficiently.

Medication Management Through Telehealth

Most migraine medications can be prescribed through telehealth, including triptans, gepants, CGRP monoclonal antibodies, and standard oral preventive medications. Controlled substances including opioids and some anti-nausea medications may require in-person prescribing in some jurisdictions, though prescribing rules vary by state.

When to Transition to In-Person Care

Telehealth is most effective as a complement to rather than a complete replacement for in-person care. Situations that warrant transitioning from telehealth to in-person evaluation include new or worsening neurological symptoms, failure to respond to multiple treatment trials, consideration of procedural treatments, diagnostic uncertainty that has not resolved with telehealth evaluation, and any situation where the clinician determines that physical examination is needed to guide clinical decision-making.